Research Paper Advance Articles
DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility
Figure 1. Correlation between DNAmAge/AgeAccelDiff/IEAA and chronologic age by BC status. (AgeAccelDiff, epigenetic age acceleration measured as departure of DNAmAge from chronologic age; IEAA, intrinsic epigenetic age acceleration measured as residuals by regressing DNAmAge on chronologic age, adjusted for cell composition; BC, breast cancer; DNAmAge, DNA methylation–based marker of aging). (A) DNAmAge (B) AgeAccelDiff (C) IEAA.